# Exploring Preeclampsia: A Comprehensive Overview

## TL;DR

This paper reviews preeclampsia, a pregnancy complication marked by high blood pressure and proteinuria, focusing on its causes, diagnosis using biomarkers, and management strategies.

## Contribution

The paper consolidates current knowledge on preeclampsia biomarkers and diagnostic approaches for clinical use.

## Key findings

- sFlt-1 and PlGF biomarker imbalance is critical for diagnosing and predicting preeclampsia.
- Elevated sFlt-1 and reduced PlGF correlate with increased severity and adverse outcomes in high-risk pregnancies.
- Multidisciplinary management is essential for maternal and fetal well-being in preeclampsia cases.

## Abstract

Preeclampsia remains a significant complication of  pregnancy which emerges after the 20th week mark  and is identified by proteinuria and hypertension.  This review explores the multifaceted nature of  preeclampsia, beginning with its complex pathology  involving endothelial, platelet dysfunction and the  imbalance in the factors that regulate angiogenesis.  Diagnosis relies on monitoring blood pressure and  assessing proteinuria, supported by laboratory tests  and imaging studies to detect organ involvement.  Biomarkers including Soluble fms-like tyrosine  kinase (sFlt-1) and placental growth factor (PlGF)  play a critical role in early detection and risk  stratification. The imbalance in the ratio between  these two biomarkers serves as a key in diagnosing  and predicting preeclampsia. Vascular homeostasis is  upset by this imbalance, which results in clinical  symptoms such as hypertension and urinary protein  excretion. Elevated sFlt-1 and reduced PlGF in high risk pregnancies, including those with chronic  hypertension, correlate with greater clinical severity  and predict adverse outcomes for maternal and fetal  health. Management strategies include the use of  antihypertensive medicines, fetal monitoring and  delivery of the fetus based on disease severity.  Despite ongoing research into predictive biomarkers  and preventative measures, preeclampsia remains a  challenge and necessitates a multidisciplinary  approach for the well-being of both the fetus and the  mother. This review serves as a comprehensive resource for clinicians and healthcare workers and by consolidating current knowledge and practical  approaches allows them to stay updated on the  evolving role of biomarkers in improving diagnostic  accuracy.